Lindell Wigginton

Recent publications · Crossref

5 total works indexed

1. Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

   · 2012 · cited 10,738x

2. Accounting for common method variance in cross-sectional research designs.

   · 2001 · cited 6,989x

3. Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

   · 2012 · cited 6,714x

4. Nivolumab plus Ipilimumab in Advanced Melanoma

   · 2013 · cited 3,598x

5. Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab

   · 2014 · cited 1,916x

via Crossref · CC0

Wikidata facts

Image

Lindell Wigginton 2020.jpg